iBio, Inc. (IBIO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 8.01M |
| Enterprise Value | 2.94M |
| P/E Ratio | -2.62 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 79.47 |
| Price/Book Ratio | 2.33 |
| Enterprise/Revenue | -71.55 |
| Enterprise/EBITDA | 0.81 |
Fiscal Year
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -92.02 |
| Operating Margin | -79.85 |
AD
Management Effectiveness
| Return On Assets | -0.32 |
| Return On Equity | -0.54 |
Income Statement
| Revenue | 400,000 |
| Revenue/Share | 0 |
| Gross Profit | 400,000 |
| EBITDA | -17.04M |
| Net Income | -18.38M |
| Diluted EPS | -1.75 |
Balance Sheet
| Total Cash | 74.8M |
| Total Cash/Share | 0.63 |
| Total Debt | 2.33M |
| Total Debt/Equity | 0.03 |
| Current Ratio | 11.88 |
| Book Value Per Share | 0.65 |
Price History
| 52-Week Change | 85.37 |
| 52-Week High | 3.82 |
| 52-Week Low | 0.56 |
| Moving Average 50 Days | 1.68 |
| Moving Average 200 Days | 1.78 |
Statistics
| Average Volume | 955,937 |
| Shares Outstanding | 15.79M |
| % Held by Institutions | 19.6 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | November 29, 2023 |
AD
